Response to neoadjuvant chemoradiotherapy in rectal cancer is associated with RAS/AKT pathway dysregulation and high tumour mutational burden

Joanne D Stockton, Louise Tee, Celina Whalley, Jonathan James, Mark Dilworth, Rachel Wheat, Thomas Nieto, Ian Geh, Andrew D Beggs

Research output: Working paper/PreprintPreprint

Original languageEnglish
Publication statusPublished - 4 Feb 2020

Cite this